Brief: Medivir: New Data From Phase I Study Of birinapant In Combination With Keytruda Presented At ASCO

Medivir AB

03/06/2019 07:40

June 3 (Reuters) - Medivir AB  MVIRb.ST :
    * NEW DATA FROM THE PHASE I STUDY OF BIRINAPANT IN
COMBINATION
WITH KEYTRUDA® PRESENTED AT ASCO
    * COMBINATION OF BIRINAPANT AND KEYTRUDA® EVALUATED IN 19
PATIENTS
WITH ADVANCED SOLID TUMORS WAS WELL TOLERATED

Source text for Eikon:  ID:nWkrb38tPM 
Further company coverage:  MVIRb.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))